ASKA Pharmaceutical Holdings Co.,Ltd. (TYO:4886)

Market Cap	66.90B +25.1%
Revenue (ttm)	68.70B +7.4%
Net Income	4.91B -5.4%
EPS	172.94 -5.5%
Shares Out	28.40M
PE Ratio	13.62
Forward PE	12.14
Dividend	55.00 (2.38%)
Ex-Dividend Date	Mar 30, 2026

Volume	123,800
Average Volume	134,880
Open	2,359.00
Previous Close	2,307.00
Day's Range	2,309.00 - 2,379.00
52-Week Range	1,920.00 - 2,942.00
Beta	0.24
RSI	49.14
Earnings Date	May 11, 2026

About TYO:4886

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and other businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, imports, exports, and sells veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1920
• Employees: 1,632
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4886

Financial Performance

In fiscal year 2025, TYO:4886's revenue was 64.14 billion, an increase of 2.06% compared to the previous year's 62.84 billion. Earnings were 5.10 billion, a decrease of -32.39%.